@noobie123 agree! kanger had to wait for main stakeholder to sell-off....now that he's done there probably could emerge new stakeholder. beside kanger, the rest never really look into the logistics of handling vaccines. so far i see kanger doing that. also they had appointed quite a high level zueligg pharma guy to guide them in this bizness!! Thumbs-up!!!
Georges Makhoul, Director. Mr. Makhoul is CEO of Constellation Holdings and was previously President of Morgan Stanley Investment Banking Europe, Middle East, and North Africa; and led National Science Foundation Research Center atColumbia University.